ArticleDrug safety2016

Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost-Utility Analysis.

Marita Mann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.